AQR CAPITAL MANAGEMENT LLC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1167557
Greenwich, CT
Position in MRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$529,279
+$295,704 QoQ
Shares Held
84,821
+2.8% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 177 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. MRVI ranks #181 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in MRVI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $529,279 | 84,821 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $233,575 | 82,536 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $361,173 | 111,131 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $176,732 | 61,580 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $144,212 | 59,840 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $34,313 | 15,527 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $279,922 | 51,362 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,654,786 | 319,469 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,534,772 | 773,013 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $24,500,335 | 2,825,875 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $22,951,926 | 3,504,111 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $17,490,030 | 1,749,003 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $12,046,720 | 969,165 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,101,676 | 1,292,054 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,901,930 | 1,460,652 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $21,899,634 | 857,800 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,851,107 | 593,140 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,348,730 | 151,651 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $215,030 | 5,132 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||